Get the Stockscreener App
2.93
2.45%
0.07
Grace Therapeutics Inc stock is traded at $2.93, with a volume of 9,125.
It is up +2.45% in the last 24 hours and up +4.64% over the past month.
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.
See More
Previous Close:
$2.86
Open:
$2.91
24h Volume:
9,125
Relative Volume:
0.31
Market Cap:
$40.88M
Revenue:
-
Net Income/Loss:
$-11.61M
P/E Ratio:
-2.2632
EPS:
-1.2946
Net Cash Flow:
$-11.82M
1W Performance:
+2.81%
1M Performance:
+4.64%
6M Performance:
-22.89%
1Y Performance:
+0.00%
1-Day Range:
$2.905
$2.94
1-Week Range:
$2.80
$2.9799
52-Week Range:
$1.75
$4.965
Grace Therapeutics Inc Stock (GRCE) Company Profile
Name
Grace Therapeutics Inc
Sector
Industry
Phone
609-322-1602
Address
103 CARNEGIE CENTER, PRINCETON
Compare GRCE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
2.93 | 40.88M | 0 | -11.61M | -11.82M | -1.2946 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
517.30 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
315.09 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
546.42 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
256.01 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-02-25 | Initiated | TD Cowen | Buy |
| Sep-01-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-06-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jan-13-20 | Downgrade | B. Riley FBR | Buy → Neutral |
| Aug-29-19 | Initiated | B. Riley FBR | Buy |
| Jul-18-19 | Initiated | Oppenheimer | Outperform |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Grace Therapeutics Inc Stock (GRCE) Latest News
Healthy Blue Louisiana and Grace at the Greenlight Partner to Support Vulnerable Communities in New Orleans - Yahoo Finance
Moderna | History, Innovation, Challenges, & Facts - Britannica
Grace Therapeutics to Participate in the 2025 BIO International Conference | GRCE Stock News - GuruFocus
Grace Therapeutics to Participate in the 2025 BIO International Conference - The Manila Times
Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025 - The Manila Times
CarMax (KMX) Projected to Post Quarterly Earnings on Friday - Defense World
Darden Restaurants (DRI) Projected to Post Quarterly Earnings on Friday - Defense World
Sidoti Csr Issues Optimistic Forecast for STRL Earnings - Defense World
Baird R W Upgrades Urban Outfitters (NASDAQ:URBN) to Strong-Buy - Defense World
Quantum Computing (NASDAQ:QUBT) Stock Price Down 2.8% After Insider Selling - Defense World
Financial Analysis: Bridgeline Digital (NASDAQ:BLIN) & Twilio (NYSE:TWLO) - Defense World
Standard Industries Announces Molecule.one as Winner of $1 Million AI Challenge - Yahoo Finance
Weiss Ratings Reaffirms “Sell (D-)” Rating for 8X8 (NASDAQ:EGHT) - Defense World
Saving grace: High interest rates benefit savers if they know where to look - Yahoo News
TWG Faces Critical 6-Month Countdown: Nasdaq Grants Last Chance to Avoid Delisting - Stock Titan
Nvidia's Grace-Hopper drives supercomputer gains, but AMD holds ground: Wells Fargo (NVDA:NASDAQ) - Seeking Alpha
Grace Therapeutics, Inc. (NASDAQ:GRCE): When Will It Breakeven? - simplywall.st
Bank of America Corp DE Reduces Stock Position in Invesco Pennsylvania Value Municipal Income Trust (NYSE:VPV) - Defense World
Bank of America Corp DE Has $1.13 Million Stake in Nuveen ESG Large-Cap ETF (BATS:NULC) - Defense World
GRCE: Progress Report - MSN
Bank of America Corp DE Acquires 10,787 Shares of SpartanNash (NASDAQ:SPTN) - Defense World
Global Atomic (TSE:GLO) Stock Price Down 2.1% – Time to Sell? - Defense World
Updated: What the first five participants for FDA's Operation Warp Speed for rare diseases are tackling - Endpoints News
Kimball Electronics, Inc. (NASDAQ:KE) Shares Sold by Nuveen Asset Management LLC - Defense World
CoreWeave rises after results of largest-ever Nvidia Grace Blackwell GPU clusters - Seeking Alpha
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 608 Shares of Kimball Electronics, Inc. (NASDAQ:KE) - Defense World
Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors - GlobeNewswire
Grace & Mercy Foundation Inc. Sells 40,273 Shares of Amazon.com, Inc. (NASDAQ:AMZN) - Defense World
Northern Trust Corp Has $1.83 Million Stock Holdings in Copa Holdings, S.A. (NYSE:CPA) - Defense World
This Grace Therapeutics Insider Increased Their Holding By 12% Last Year - Yahoo
Baird Financial Group Inc. Has $648.41 Million Holdings in NVIDIA Co. (NASDAQ:NVDA) - Defense World
Corcept Therapeutics Incorporated (NASDAQ:CORT) Stock Holdings Lessened by Cetera Investment Advisers - Defense World
Hunter Syndrome Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail
Comerica Bank Makes New Investment in Simplify Interest Rate Hedge ETF (NYSEARCA:PFIX) - Defense World
Dimensional Fund Advisors LP Sells 101,689 Shares of Broadwind, Inc. (NASDAQ:BWEN) - Defense World
Trump tariffs live updates: US cuts the 'de minimis' tariffs on small shipments from China - Yahoo Finance
Mariner LLC Acquires New Holdings in Orion Energy Systems, Inc. (NASDAQ:OESX) - The AM Reporter
21,184 Shares in Kimball Electronics, Inc. (NASDAQ:KE) Purchased by Raymond James Financial Inc. - Defense World
30,000 Shares in Broadwind, Inc. (NASDAQ:BWEN) Purchased by Mariner LLC - Defense World
Trump tariffs live updates: Trump set to unveil 'full' US-UK trade deal, first since 'Liberation Day' tariffs - Yahoo Finance
Traumatic Brain Injury Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Neuren Pharma, NeuroVive Pharma, Stemedica Cell Techn, Grace Laboratorie - Barchart.com
Trump tariffs live updates: No plans for Trump-Xi talks, Ackman floats China pause - Yahoo Finance
Grace Therapeutics (NASDAQ:GRCE) Research Coverage Started at TD Cowen - Defense World
TD Cowen starts Grace Therapeutics stock with Buy, $12 target By Investing.com - Investing.com Canada
Biotech Stock Ends Week On High Note Following Bullish Coverage Initiation - The Globe and Mail
TD Cowen Initiates Coverage on Grace Therapeutics With Buy Rating, $12 Price Target - marketscreener.com
Grace Therapeutics (GRCE) Receives Positive Buy Rating with Prom - GuruFocus
Grace Therapeutics (GRCE) Receives Positive Buy Rating with Promising Outlook | GRCE Stock News - GuruFocus
Trump tariffs live updates: China eases some US tariffs as Trump says he wants concessions - Yahoo Finance
United Rentals, Inc [URI] Records 200-Day SMA of $730.81 - knoxdaily.com
Onward Therapeutics Announces IMPD Approval for Its Subsidiary Emercell to Start Clinical Investigation of Allogeneic NK Cell Therapy OT-C001 in Combination with Rituximab - BioSpace
Grace Therapeutics Inc Stock (GRCE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.59%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):